These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23173329)

  • 1. [Modern toxicology of magnetic nanomaterials].
    Cywińska MA; Grudziński IP
    Rocz Panstw Zakl Hig; 2012; 63(3):247-56. PubMed ID: 23173329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety of medicinal nanoproducts: new areas of toxicological research].
    Grudziński IP
    Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
    Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
    Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabricated nanoparticles: current status and potential phytotoxic threats.
    Yadav T; Mungray AA; Mungray AK
    Rev Environ Contam Toxicol; 2014; 230():83-110. PubMed ID: 24609519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotoxicology and in vitro studies: the need of the hour.
    Arora S; Rajwade JM; Paknikar KM
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):151-65. PubMed ID: 22178382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological aspects for nanomaterial in humans.
    Dusinska M; Magdolenova Z; Fjellsbø LM
    Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of toxicity of nanoparticles using insects as biological models.
    Zhou Y; Rocha A; Sanchez CJ; Liang H
    Methods Mol Biol; 2012; 906():423-33. PubMed ID: 22791454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in benefits and hazards of engineered nanoparticles.
    Radad K; Al-Shraim M; Moldzio R; Rausch WD
    Environ Toxicol Pharmacol; 2012 Nov; 34(3):661-72. PubMed ID: 22964156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the toxicity of selected types of nanochemicals.
    Kumar V; Kumari A; Guleria P; Yadav SK
    Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer hyperthermia using magnetic nanoparticles.
    Kobayashi T
    Biotechnol J; 2011 Nov; 6(11):1342-7. PubMed ID: 22069094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical methods to assess nanoparticle toxicity.
    Marquis BJ; Love SA; Braun KL; Haynes CL
    Analyst; 2009 Mar; 134(3):425-39. PubMed ID: 19238274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and characterization of functional nanoparticles for enhanced bio-performance.
    del Pino P; Mitchell SG; Pelaz B
    Methods Mol Biol; 2013; 1051():165-207. PubMed ID: 23934805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology of nanomaterials used in nanomedicine.
    Zhao J; Castranova V
    J Toxicol Environ Health B Crit Rev; 2011; 14(8):593-632. PubMed ID: 22008094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine: An unresolved regulatory issue.
    Chan VS
    Regul Toxicol Pharmacol; 2006 Dec; 46(3):218-24. PubMed ID: 17081666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.